Compare GSBC & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GSBC | PACB |
|---|---|---|
| Founded | 1923 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 627.5M | 715.5M |
| IPO Year | N/A | 2010 |
| Metric | GSBC | PACB |
|---|---|---|
| Price | $65.40 | $2.13 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $59.50 | $2.00 |
| AVG Volume (30 Days) | 50.2K | ★ 8.6M |
| Earning Date | 01-20-2026 | 11-05-2025 |
| Dividend Yield | ★ 2.63% | N/A |
| EPS Growth | ★ 18.31 | N/A |
| EPS | ★ 6.00 | N/A |
| Revenue | ★ $228,683,000.00 | $154,584,000.00 |
| Revenue This Year | N/A | $4.41 |
| Revenue Next Year | N/A | $11.76 |
| P/E Ratio | $10.89 | ★ N/A |
| Revenue Growth | ★ 7.86 | N/A |
| 52 Week Low | $47.58 | $0.85 |
| 52 Week High | $66.98 | $2.73 |
| Indicator | GSBC | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 76.32 | 49.91 |
| Support Level | $61.24 | $2.30 |
| Resistance Level | $62.76 | $2.47 |
| Average True Range (ATR) | 1.14 | 0.20 |
| MACD | 0.56 | -0.03 |
| Stochastic Oscillator | 100.00 | 5.69 |
Great Southern Bancorp Inc is a bank holding company. It is principally engaged in the business of originating residential and commercial real estate loans, construction loans, commercial business loans, and consumer loans. The bank provides various services such as Business Banking, Merchant Services, Debit and Credit cards, Online Banking, Mobile Banking, VIP Banking, Overdraft Protection, and various other related services. It operates into a single segment which is Community Banking.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.